|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Advances to Suppliers | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Other receivable | ||||||||||||||||||||
| Deposit on acquisition of Pegasus Specialty Vehicles LLC | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Advances to Pegasus Specialty Vehicles, LLC | ||||||||||||||||||||
| Loan receivable | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Fixed assets: | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Total fixed assets | ||||||||||||||||||||
| Intangible, net | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' DEFICIT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total due to related parties | ||||||||||||||||||||
| Loans payable, related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total notes payable | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Senior promissory note | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Deficit: | ||||||||||||||||||||
| Preferred Stock, value | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Common stock, $ 0.0001 par value; 200,000,000 shares authorized; 195,248,774 and 110,401,280 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively. | ||||||||||||||||||||
| Preferred stock issuable | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Common stock issuable | ||||||||||||||||||||
| Stock subscription receivable | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders' deficit | ||||||||||||||||||||
| Total liabilities and shareholders' deficit | ||||||||||||||||||||
Loading...
